Healthcare -
Biotechnology - NASDAQ - US
$ 0.3559
0.993 %
$ 4.01 M
Market Cap
-0.01
P/E
CYCC - LONG-TERM DEBT
Long-term Debt CYCC - Cyclacel Pharmaceuticals, Inc.
37 K
LAST VALUE
11.06%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR